Reduced Viral Fitness and Lack of Cross-Class Resistance with Integrase Strand Transfer Inhibitor and Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations

Por Andreatta, Kristen N., Goodman, Derrick D., Miller, Michael D., White, Kirsten L.
Publicado no Antimicrob Agents Chemother (2015)

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

Por Feng, Joy Y, Ly, John K, Myrick, Florence, Goodman, Derrick, White, Kirsten L, Svarovskaia, Evguenia S, Borroto-Esoda, Katyna, Miller, Michael D
Publicado em 2009

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Por Abram, Michael E., Hluhanich, Rebecca M., Goodman, Derrick D., Andreatta, Kristen N., Margot, Nicolas A., Ye, Linda, Niedziela-Majka, Anita, Barnes, Tiffany L., Novikov, Nikolai, Chen, Xiaowu, Svarovskaia, Evguenia S., McColl, Damian J., White, Kirsten L., Miller, Michael D.
Publicado em 2013